The Johns Hopkins Asthma & Allergy Center, Baltimore, MD 21224, USA.
Proc Am Thorac Soc. 2011 May;8(2):143-8. doi: 10.1513/pats.201103-030MS.
Asthma is a heterogeneous disease for which a strong genetic basis is firmly established. Although the generally accepted definition includes three domains of symptoms (variable airway obstruction, airway hyper-responsiveness, and airway inflammation), there is general agreement that, rather than being a single disease entity, asthma consists of related, overlapping syndromes. A considerable proportion of asthma is IgE-mediated, but the observation that not all individuals with asthma are atopic adds to the heterogeneity. Although a genetic basis for asthma is undeniable, elucidation of polymorphisms that are "causal" is greatly hampered by variability in the clinical phenotype, which is likely due to the multiple molecular mechanisms underlying the complex pathological processes involved in disease development and progression. One objective of this review is to consider progress that has been made to date in gene discovery in the field of asthma, with a focus on the evolution of molecular genetic methods that have led to the discoveries thus far, and with a particular focus on the major advances owed to the published genome-wide association studies (GWAS) on asthma to date. A second objective is to consider a Darwinian approach toward understanding the genetic underpinnings of asthma, including evidence supporting a modified Hygiene Hypothesis, which suggests that there are co-associations between asthma risk polymorphisms and polymorphisms associated with another IgE-mediated disease, schistosomiasis. The overall conclusion is that the huge research efforts and expense committed to asthma genetics have changed the perception about disease etiology in general and the functional relevance of the asthma genes identified thus far in particular.
哮喘是一种具有很强遗传基础的异质性疾病。虽然普遍接受的定义包括三个症状领域(气道阻塞的可变性、气道高反应性和气道炎症),但人们普遍认为,哮喘不是一种单一的疾病实体,而是由相关的、重叠的综合征组成。相当一部分哮喘是 IgE 介导的,但并非所有哮喘患者都是特应性的,这增加了哮喘的异质性。虽然哮喘的遗传基础是不可否认的,但由于临床表型的可变性,阐明“因果”多态性受到了极大的阻碍,这可能是由于疾病发展和进展所涉及的复杂病理过程的多种分子机制所致。本次综述的一个目的是考虑迄今为止在哮喘领域基因发现方面取得的进展,重点是分子遗传方法的演变,这些方法导致了迄今为止的发现,并特别关注迄今为止发表的哮喘全基因组关联研究(GWAS)所取得的重大进展。第二个目的是从达尔文的角度来理解哮喘的遗传基础,包括支持修正的卫生假说的证据,该假说表明哮喘风险多态性与另一种 IgE 介导的疾病血吸虫病相关的多态性之间存在共同关联。总体结论是,投入到哮喘遗传学研究中的巨大研究努力和费用改变了人们对疾病病因的普遍看法,特别是对迄今为止发现的哮喘基因的功能相关性的看法。